ATOPY Index is made and published by Colgate-Palmolive Company. AppBrain is an independent app data site and isn't affiliated with Colgate-Palmolive Company. The app name, icon, screenshots and description belong to Colgate-Palmolive Company and are shown as published on the App Store.
AppBrain's verdict
Removed- Rating on App Store
- 5.00
- 1 ratings
- Last updated
- April 19, 2018
ATOPY Index is no longer on the App Store. It had too few ratings to say what users thought.
Competitors
Similar apps and more from Colgate-Palmolive CompanyMore from Colgate-Palmolive Company
Also available on Google Play
Releases
Updates seen on the App Store- Version
- 2.5.0
- Launched
- August 2017
No changelog data
User feedback
Ratings and reviews on the App StoreComments on ATOPY Index for iOS
We don't have enough comments to show example comments. Please check back later.
Technology
Found in the app by AppBrain- Price
- Free
- App size
- 59.0 MB
- Content rating
- Medium
Technologies used by ATOPY Index
About the app and developer
About ATOPY Index
ATOPY Index was a medical app developed by Colgate-Palmolive Company. It was removed from the App Store Jun 24, 2025.
User Ratings
ATOPY Index was rated 5.00 out of 5 stars, based on one rating ratings.
App Information
ATOPY Index was free. The app size was 59.02 MB. The last available version was 2.5.0. The last update was on April 19, 2018.
Technical Requirements
The app had a content rating of Medium Maturity. The app had been available on the App Store since August 2017.
Developer information for Colgate-Palmolive Company
Address:
Frequently asked questions about ATOPY Index
Is ATOPY Index free?
Yes. ATOPY Index was free on the App Store.
Is ATOPY Index still available?
No. ATOPY Index was removed from the App Store. We last saw it there Jun 24, 2025.
How large is ATOPY Index?
ATOPY Index is 59.02 MB.
Is ATOPY Index suitable for children?
App Store gives ATOPY Index a medium maturity rating, so it is not meant for young children.
How do people rate ATOPY Index?
ATOPY Index had one rating of 5.00 stars on the App Store.
Who made ATOPY Index?
ATOPY Index was developed by Colgate-Palmolive Company. It was listed in the medical category on the App Store.
What are the best alternatives to ATOPY Index?
People looking at ATOPY Index also look at these medical apps: PetDialog Studies, Virbac DailyDerma Monitoring, Shukla Ortho Search, The Orthotic Revolution 3D, AllergyVax.
Store listing
By Colgate-Palmolive Company, from the App StoreSimilar apps
Description by Colgate-Palmolive Company Written by the developer, not by AppBrain. Click to read.
Hill’s Atopy Index is a free smartphone web app for veterinarians that helps to easily assess the Canine Atopic Dermatitis Extent and Severity Index (CADESI -4)* before and after treatment.
Simple, easy and visual way to complete the CADESI-4 assessment in few minutes!
20 body sites
3 lesion types
Scale of 0-3
Visual Report & Tracker
**Key features:**
Assess total the dermatological index based on a validated severity scale in just minutes
Visualize the severity index using the usual lateral and ventral view
Track the evolution of the total score and severity by each affected area at each visit
Send an e-mail to yourself with a summary report for your clinic records or to further share with your client
Download free the Hill’s Dermatology Diagnostic Guide to learn more about diagnosis and multimodal management of Canine Atopic Dermatitis.
Atopy Index app was developed by Hill’s Pet Nutrition with permission and is intended for use by veterinarians only. This app is not designed for the diagnosis of atopic dermatitis, only as an aid in its management. Proper diagnosis and patient management are always the responsibility of the attending veterinary surgeon. Hill’s cannot be held responsible for any claims, by the pet owner or veterinarian, related to the diagnosis or patient management that have been applied or recommended by the veterinary healthcare team as a result of using this app.
**What is Canine Atopic Dermatitis and CADESI-4?**
Canine atopic dermatitis (CAD) is a genetically-predisposed inflammatory and pruritic allergic skin disease in dogs. It is caused by allergies against environmental allergies, such as pollen, house dust mites, moulds, etc. CAD accounts for around 60% of all allergies seen in dogs. It is characterised by a vicious cycle of inflammation, pruritus and excoriation, leading to repeated skin damage.
CAD is difficult to diagnose. The diagnosis is based on excluding other causes of dermatitis, such as fleas, food allergy, etc. The Canine Atopic Dermatitis Extent and Severity Index (CADESI)-4 has been developed by leading veterinary dermatologists. With this scoring system the vet can see how serious the disease is, and once treated, measure the progress. It is also a very visual way to explain the situation and improvements to clients.
Management of patients with CAD is equally difficult, and often requires life-long multimodal management, including environmental modification, drugs, shampoos, topicals and specially formulated nutrition.
* References:
1. Plant JD, Gortel K, Kovalik M, et al. Development and validation of the Canine Atopic Dermatitis Lesion Index, a scale for the rapid scoring of lesion severity in canine atopic dermatitis. Veterinary Dermatology 2012; 23:515-e103.
2. Olivry T, Saridomichelakis M, Nuttall T, et al. Validation of the Canine Atopic Dermatitis Extent and Severity Index (CADESI)-4, a simplified severity scale for assessing skin lesions of atopic dermatitis in dogs. Veterinary Dermatology 2014; 25:77-e25.
3. Olivry T., Deboer D.J., Griffin C.E., Halliwell R.E., Hill P.B., Hillier A., Marsella R., Sousa C.A. : The ACVD task force on canine atopic dermatitis : forewords and lexicon. Vet. Immunol. Immunopathol., 2001, 81, 143-146.